WithdrawnPhase 1NCT02745756

A Combined Cell Therapy Approach to the Treatment of Neuroblastoma

Studying Neuroblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Principal Investigator
Shari Pilon-Thomas, Ph.D.
H. Lee Moffitt Cancer Center and Research Institute
Intervention
Autologous Hematopoietic Progenitor Cell Transplant(procedure)
Eligibility
21 years · All sexes
Timeline
2016 – 2017

Collaborators

Johns Hopkins All Children's Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02745756 on ClinicalTrials.gov

Other trials for Neuroblastoma

Additional recruiting or active studies for the same condition.

See all trials for Neuroblastoma →

← Back to all trials